Big advance in contact-free movement of tiny amounts of liquid

Acoustic liquid handlers have been available for more than a decade. They enable nanoliters of liquid to be accurately transferred from one well to another, without any risk of contamination or loss. The liquid handlers adapt to different fluid types and enable direct dilution of a liquid rather than serial dilution, which is prone to errors and cross-contamination. Over the past 15 years, acoustic liquid handlers have helped reduce experiment time, improved efficiency, and provided cleaner results in fields such as drug discovery and synthetic biology. However, there is room for improvement. The acoustic instrumentation can be noisy, and some machines require tricky maintenance. With its next generation of Echo® Liquid Handlers, Labcyte is addressing these concerns, as well as introducing newly developed acoustic sample tubes as an alternative to the standard well plates.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Simplifying ChIP from Primary Cells and Clinical Samples for Epigenetic Applications

Biocompare

Mapping the epigenetic and transcription factor landscape is essential for understanding gene regulatory mechanisms and holds huge potential for identification of biomarkers and targets for epigenetic therapy.
Watch Now

Viruses in Soils

labroots

Viruses outnumber bacteria in soil by as much as 1000:1. However, there are few studies which examine the ways viral communities impact the soil microbiome, chemical cycles, and plants. Recent advances in viral ecology make it a discussion of soil viral ecology especially timely.
Watch Now

Predicting TCR Specificity with Multiomic Single-Cell Sequencing

T cell receptors (TCRs) allow the adaptive immune system to recognize and respond to a vast array of threats, ranging from viruses to malignant cells. Single-cell sequencing has made it possible to explore an individual’s TCR repertoire and quantify changes due to an immune response. To fully unlock the great potential of these measurements we need to know which antigens each TCR binds.
Watch Now

Cell and Gene Therapies: From Concept to Commercialization

genengnews.com

The voyage of a cell or gene therapy from initial hypothesis to commercial delivery is complex and challenging. It requires a broad spectrum of scientific expertise, innovative technologies, and optimized processes to ensure these advanced therapeutics make it to market. In this GEN webinar, our panelists—two industry leaders—will discuss what it takes to develop a cell or gene therapy from concept to commercialization, alongside a conversation about innovations that are likely to shape the future of advanced therapy discovery and biomanufacturing.
Watch Now

Spotlight

resources